Rhode Island 2022 Regular Session

Rhode Island House Bill H7133

Introduced
1/20/22  
Refer
1/20/22  
Report Pass
4/26/22  
Engrossed
5/3/22  
Refer
5/20/22  
Report Pass
6/21/22  
Engrossed
6/23/22  
Engrossed
6/24/22  

Caption

Pharmaceutical Redistribution Program Act

Impact

If enacted, H7133 will significantly affect state laws relating to health and safety by providing a structured framework for the donation and redistribution of prescription drugs. It will introduce definitions for key terms, such as 'donor', 'redistributor', and 'recipient', while also establishing a clear process for participation that prioritizes individuals without insurance or those underinsured. The law aims to minimize waste by facilitating the repurposing of unused medications rather than allowing them to expire unused.

Summary

House Bill 7133, titled the Pharmaceutical Redistribution Program Act, seeks to establish a voluntary program for the redistribution of unused non-controlled substance prescription drugs in Rhode Island. The intent of this legislation is to address the public health issue of individuals having difficulty accessing essential medications due to cost prohibitions. Through this program, donated medications are intended to be provided to those most in need, ensuring that underinsured and uninsured residents receive the medications they require without financial barriers.

Sentiment

The sentiment surrounding the bill has been generally supportive, with advocates highlighting its potential to enhance public health by increasing access to necessary medications for the financially disadvantaged population. There is a recognition of the benefits of reducing waste associated with unused medications. However, there are also concerns about the complexities inherent in managing the redistribution process and ensuring compliance with regulations to maintain safety and efficacy standards.

Contention

Notable points of contention relate primarily to the parameters of participating in the donation and redistribution program. Critics have raised questions about the balance between facilitating drug access and ensuring proper oversight, particularly regarding the conditions under which drugs can be donated and the liability protections in place for those involved in the redistribution process. Ensuring that donated drugs remain safe and effective while navigating the legal implications of drug redistributions will be critical for the program's success.

Companion Bills

No companion bills found.

Previously Filed As

RI HB07179

An Act Concerning Pharmaceutical Marketing And Pharmaceuticals.

RI HB1060

Modern Authentication of Pharmaceuticals Act of 2025

RI SB2104

PHARMACEUTICALS-SOCIAL MEDIA

RI SB3046

PHARMACEUTICALS-SOCIAL MEDIA

RI HB646

AN ACT relating to the use of pharmaceuticals to intentionally terminate life.

RI SB3134

Combating Counterfeit Pharmaceuticals Act of 2025

RI SB0317

Health: pharmaceuticals; program for the wholesale importation of pharmaceuticals from Canada; provide for. Creates new act.

RI H5126

Makes it a felony to price gouge prescriptions or pharmaceuticals in time of a shortage.

RI H7214

Makes it a felony to price gouge prescriptions or pharmaceuticals in time of a shortage.

RI SB0003

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

Similar Bills

NJ S1410

Amends statutory law to change title of "physician assistant" to "physician associate."

NJ S4094

Revises statutory law to change title of "physician assistant" to "physician associate."

NJ A4958

Revises statutory law to change title of "physician assistant" to "physician associate."

ID H0329

Amends and adds to existing law to provide certain property tax exemptions for certain utilities and to provide for a tax on rate-regulated electric companies and gas companies.

CA AB1612

Disposition of controlled substances.

MA H2227

Replacing archaic and stigmatizing language for substance use

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25